Research progress in immune-related liver injury caused by immune checkpoint inhibitors / 国际生物医学工程杂志
International Journal of Biomedical Engineering
;
(6): 169-174, 2023.
Article
in Chinese
| WPRIM
| ID: wpr-989334
ABSTRACT
In recent years, immune checkpoint inhibitors (ICIs) have made great progress in the treatment of tumor patients, prolonging their survival. However, the expansion of immunity against tumors with ICIs may also cause an imbalance in immune tolerance, leading to immune-related adverse events (irAEs). Immune-mediated liver injury caused by ICIs (ILICI) is one of the more common types of irAEs. In this review paper, the definition, epidemiology, risk factors, pathogenesis, pathology, clinical manifestations, treatment, recurrence, and re-treatment of ILICI were summarized to provide a basis for clinical diagnosis and treatment.
Full text:
Available
Index:
WPRIM (Western Pacific)
Language:
Chinese
Journal:
International Journal of Biomedical Engineering
Year:
2023
Type:
Article
Similar
MEDLINE
...
LILACS
LIS